Your browser doesn't support javascript.
loading
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.
Sandul, Amy L; Nwana, Nwabunie; Holcombe, J Mike; Lobato, Mark N; Marks, Suzanne; Webb, Risa; Wang, Shu-Hua; Stewart, Brock; Griffin, Phil; Hunt, Garrett; Shah, Neha; Marco, Asween; Patil, Naveen; Mukasa, Leonard; Moro, Ruth N; Jereb, John; Mase, Sundari; Chorba, Terence; Bamrah-Morris, Sapna; Ho, Christine S.
Afiliación
  • Sandul AL; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Nwana N; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Holcombe JM; Mississippi State Department of Health, Jackson.
  • Lobato MN; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Marks S; Connecticut Department of Public Health, Hartford.
  • Webb R; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Wang SH; Mississippi State Department of Health, Jackson.
  • Stewart B; University of Mississippi Medical Center, Jackson.
  • Griffin P; Ohio State University Medical Center, Columbus.
  • Hunt G; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Shah N; Kansas Department of Health and Environment, Topeka.
  • Marco A; Nationwide Children's Hospital, Columbus, Ohio.
  • Patil N; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Mukasa L; California Department of Public Health, San Francisco ; and.
  • Moro RN; Arkansas Department of Health, Little Rock.
  • Jereb J; Arkansas Department of Health, Little Rock.
  • Mase S; Arkansas Department of Health, Little Rock.
  • Chorba T; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bamrah-Morris S; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Ho CS; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Clin Infect Dis ; 65(7): 1085-1093, 2017 10 01.
Article en En | MEDLINE | ID: mdl-28575208
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Latente / Isoniazida / Antibióticos Antituberculosos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article País de afiliación: Georgia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Latente / Isoniazida / Antibióticos Antituberculosos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article País de afiliación: Georgia